Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(3.25)
# 2,460
Out of 5,010 analysts
24
Total ratings
52.9%
Success rate
11.8%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Reiterated: Hold | $5 | $5.15 | -2.91% | 2 | Aug 11, 2026 | |
| ILMN Illumina | Downgraded: Hold | $185 | $272.00 | -31.99% | 1 | Aug 5, 2026 | |
| VMD Viemed Healthcare | Downgraded: Hold | $11 | $9.23 | +19.18% | 1 | Aug 5, 2026 | |
| SMTI Sanara MedTech | Downgraded: Hold | $35 | $35.09 | -0.26% | 2 | Aug 3, 2026 | |
| JNJ Johnson & Johnson | Upgraded: Buy | $280 | $267.57 | +4.65% | 1 | Jul 16, 2026 | |
| NAGE Niagen Bioscience | Initiated Coverage: Buy | $9 | $2.95 | +205.08% | 1 | Jul 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Initiated Coverage: Buy | $27 | $13.70 | +97.08% | 1 | Jul 2, 2026 | |
| ATYR aTyr Pharma | Upgraded: Buy | $3.5 | $0.3077 | +1,037.47% | 1 | May 20, 2026 | |
| ATRA Atara Biotherapeutics | Upgraded: Hold | $10 | $8.05 | +24.22% | 1 | May 18, 2026 | |
| AMGN Amgen | Upgraded: Buy | $375 | $423.64 | -11.48% | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $245 | $227.07 | +7.90% | 1 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $5.37 | +123.46% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $15.60 | +2.56% | 1 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $86.46 | +34.17% | 1 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $3.42 | +484.80% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.87 | n/a | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $18.64 | n/a | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $5.24 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $10.88 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $28.33 | n/a | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.88 | n/a | 1 | Mar 18, 2025 |
Sionna Therapeutics
Aug 11, 2026
Reiterated: Hold
Price Target: $5
Current: $5.15
Upside: -2.91%
Illumina
Aug 5, 2026
Downgraded: Hold
Price Target: $185
Current: $272.00
Upside: -31.99%
Viemed Healthcare
Aug 5, 2026
Downgraded: Hold
Price Target: $11
Current: $9.23
Upside: +19.18%
Sanara MedTech
Aug 3, 2026
Downgraded: Hold
Price Target: $35
Current: $35.09
Upside: -0.26%
Johnson & Johnson
Jul 16, 2026
Upgraded: Buy
Price Target: $280
Current: $267.57
Upside: +4.65%
Niagen Bioscience
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $2.95
Upside: +205.08%
Arcturus Therapeutics Holdings
Jul 2, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $13.70
Upside: +97.08%
aTyr Pharma
May 20, 2026
Upgraded: Buy
Price Target: $3.5
Current: $0.3077
Upside: +1,037.47%
Atara Biotherapeutics
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $8.05
Upside: +24.22%
Amgen
May 7, 2026
Upgraded: Buy
Price Target: $375
Current: $423.64
Upside: -11.48%
May 1, 2026
Upgraded: Buy
Price Target: $245
Current: $227.07
Upside: +7.90%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $5.37
Upside: +123.46%
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $15.60
Upside: +2.56%
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $86.46
Upside: +34.17%
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $3.42
Upside: +484.80%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $1.87
Upside: n/a
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $18.64
Upside: n/a
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $5.24
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $10.88
Upside: n/a
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $28.33
Upside: n/a
Mar 18, 2025
Reiterated: Buy
Price Target: $13
Current: $2.88
Upside: n/a